API reference
Bimatoprost
- CAS number
- 155206-00-1
- Molecular formula
- C25H37NO4
- Molecular weight
- 415.6 g/mol
About this molecule
Bimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
- InChIKey
- AQOKCDNYWBIDND-FTOWTWDKSA-N
- SMILES
- CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCC2=CC=CC=C2)O)O)O
- Other CAS numbers recorded
- 1365263-66-6
- PubChem CID
- 5311027
Also known as
Bimatoprost · Lumigan · Latisse · Prostamide · bimatoprostum · DURYSTA · GANFORT COMPONENT BIMATOPROST · S01EE03
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.